Cargando…
High-dose versus low-dose iron sucrose in individuals undergoing maintenance haemodialysis: a retrospective study
BACKGROUND: Intravenous iron sucrose is becoming a prevailing treatment for individuals undergoing maintenance haemodialysis, but comparisons of dosing regimens are lacking. The aim of this retrospective review was to evaluate the safety and efficacy of proactively administered high-dose iron sucros...
Autores principales: | Liu, Luojin, Cheng, Huihui, Lv, Yukai, Yu, Weiguang, Liu, Qilong, Wu, Yanqing, Xu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550635/ https://www.ncbi.nlm.nih.gov/pubmed/34706660 http://dx.doi.org/10.1186/s12882-021-02570-0 |
Ejemplares similares
-
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients
por: Bhandari, Sunil, et al.
Publicado: (2015) -
Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience
por: Jesus-Silva, Jorge A., et al.
Publicado: (2020) -
High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis
por: Petrie, Mark C, et al.
Publicado: (2021) -
Urea Concentration and Haemodialysis Dose
por: Vartia, Aarne
Publicado: (2012) -
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol
por: Blankestijn, Peter J, et al.
Publicado: (2020)